Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release/patch. The 'Back to Top' UI element was removed, a minor UI change.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of new medical topics related to drug safety and specific diseases. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page has been updated to reflect an increase in the number of study locations from 50 to 51, with the addition of new locations in Xiamen, Chengdu, and Tianjin, China, while the previous location in Changsha has been removed.SummaryDifference0.8%
- Check46 days agoChange DetectedThe web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.